LTBR and non-small cell lung carcinoma: In conclusion, this study shows that two (CD40 rs1883832 and LTβR rs10849448) of the three studied genetic variants are associated with an increased risk for NSCLC, while CD40 rs1883832 was also significantly associated with OS of patients with NSCLC.